| Date | Time | Source | Announcement |
|---|---|---|---|
| 22 Nov 2004 | 07:00 AM | Re Alliance | |
| 22 Nov 2004 | 07:00 AM | Transaction in Own Shares | |
| 19 Nov 2004 | 04:21 PM | Statement | |
| 18 Nov 2004 | 07:00 AM | Transaction in Own Shares | |
| 12 Nov 2004 | 07:00 AM | Transaction in Own Shares | |
| 10 Nov 2004 | 07:00 AM | Transaction in Own Shares | |
| 05 Nov 2004 | 07:00 AM | Transaction in Own Shares | |
| 03 Nov 2004 | 11:00 AM | Symbicort | |
| 25 Oct 2004 | 07:00 AM | IAS/IFRS | |
| 22 Oct 2004 | 09:00 AM | Notice of Telecon re IAS/IFRS | |
| 21 Oct 2004 | 11:00 AM | 3rd Quarter Results (2 of 2) | |
| 21 Oct 2004 | 11:00 AM | 3rd Quarter Results (1 of 2) | |
| 20 Oct 2004 | 09:00 AM | Notice of Results | |
| 11 Oct 2004 | 07:00 AM | Exanta | |
| 06 Oct 2004 | 07:45 AM | Annual Business Review | |
| 05 Oct 2004 | 09:00 AM | Notice-Annual Business Review | |
| 01 Oct 2004 | 04:00 PM | Holding(s) in Company | |
| 01 Oct 2004 | 07:00 AM | Transaction in Own Shares | |
| 30 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 29 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 28 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 27 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 24 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 23 Sep 2004 | 04:00 PM | Director Shareholding | |
| 23 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 22 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 21 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 20 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 17 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 16 Sep 2004 | 11:30 AM | Nexium | |
| 15 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 14 Sep 2004 | 07:00 AM | Transaction in Own Shares | |
| 13 Sep 2004 | 07:00 AM | Exanta | |
| 02 Sep 2004 | 07:00 AM | Sale of Advanta BV | |
| 23 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 20 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 18 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 17 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 16 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 12 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 10 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 09 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 06 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 05 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 04 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 03 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 02 Aug 2004 | 07:00 AM | Transaction in Own Shares | |
| 29 Jul 2004 | 07:00 AM | Transaction in Own Shares | |
| 28 Jul 2004 | 04:00 PM | Holding(s) in Company | |
| 28 Jul 2004 | 07:00 AM | Transaction in Own Shares |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.